Owner/Developer: Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
We only use animals in research where no alternative exists. We recognise that not all research using animals can be replaced in the foreseeable future and consider it our responsibility to actively support the principles of the 3Rs (Reduce, Refine and Replace research using animals, Professor William Russell and Rex Burch, 1959) internally and externally. We have integrated these principles in all our processes and procedures and established a 3R Award to acknowledge and inspire employees who bring the 3Rs principles into action. We review animal models on a continuous basis for replacement with in vitro methods and use human cells and tissues instead of living animals wherever possible. We support the development of valid alternatives to animal experiments.
|Channel:||Website - E-mail - Audio / Video - Social media - Professional online network|
|Audience:||Scientists - Industry - General public|
|User access:||Open access|
|Updating frequency:||Frequently updated|
|Relevance:||Replacement - Reduction - Refinement|
|Purpose:||Fundamental studies - Documentation and information - Method development - Diagnosis|
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.